Partners - Creating value together to patient benefit

Tools content (print, share, increase/decrease text size):

 

Our websites

 

Middle area:

A company focused on patients’ needs

Christopher A. Viehbacher, Chief Executive Officer

Partnership is at the core of what we do. It is how we foster increased innovation internally. It is how we assist our partners to go beyond their goals. And most importantly, it is the way we ensure we are delivering the best, the most innovative and the most awaited for solutions that patients are hoping for.

New scientific discoveries are happening every day, but there is a significant challenge in translating these breakthroughs in the laboratory to treatments for patients. We realized that while we have some great expertise and science inside our own walls, it is through forming effective external partnerships that we could truly deliver on our commitment to patients.

But it is not enough to simply sign a deal. We have become recognized as a great partner and the key to our success is based on a number of elements. First, we are looking to create deep, long-lasting partnerships, not just to solely finance projects. We also want to create a scientific community amongst our partners, creating a network of the best scientists around the world, internally and externally.

We also understand that the management of partnerships, ensuring the right balance between our company and our partners, is as important as the project itself. We put a lot of focus on the development of each individual partnership: building a collaborative team, setting clear milestones and expectations together at the outset, and ensuring transparency between internal and external team members.

And, at the core of it all, the one element that is the real key to success - the trust we strive for within the partnerships.

Christopher A. Viehbacher - Chief Executive Officer

 

A well-balanced presence between established and emerging markets

With €34,947 million, Sanofi is a diversified global healthcare leader. A presence in over 100 countries ensures a well-balanced presence between established and emerging markets.

 

Based on consolidated sales 2012

Other countries: Japan, Australia, New Zealand, Canada.

Emerging Markets: World less the United States, Canada, Western Europe, Japan, Australia and New Zealand.

 

Sanofi has a strong diversified base

Sanofi offers a range of treatments adapted to patients’ needs, including a broad-based pharmaceutical product portfolio.

 

Source: Press release of February 07, 2013

 
To know more visit:

 

Right area:

Partners to your ideas - Submit your project
 
Available opportunities - Out-licensing
 

Upcoming events

American Diabetes Association (ADA) 73rd Scientific Sessions 2013

June 21-25, 2013
Chicago, IL, United States - USA

 

Tools menu:

© Sanofi 2004-2014 - All rights reserved - Update: February 12, 2013

Site complies with W3C WCAG 2.0 (new window, in english)